Titlebook: Anal Cancer; A Comprehensive Guid Jeffrey Meyer,Lisa Kachnic Book 2019 Springer Nature Switzerland AG 2019 anal cancer.lower gastrointestin

符合規(guī)定

tic disease.Details ongoing and upcoming efforts to improve This book is a comprehensive overview of the epidemiology, pathogenesis, and treatment options available for anal cancer. Anal cancer is a relatively rare disease, but one increasing in incidence. Strides have been made in developing treatm

Isometric

小平面

lipids

香料

POINT

https://doi.org/10.1007/978-3-0348-6749-8e imaging (MRI) of the pelvis and CT of the chest and abdomen. The addition of whole-body positron emission tomography-computed tomography (PET/CT) leads to further nodal evaluation and informs radiotherapeutic treatment planning for curative cases. Anal canal cancers, located between the anorectal

斑駁

可行

指數(shù)

Staging and Initial Evaluation of Anal Cancer,e imaging (MRI) of the pelvis and CT of the chest and abdomen. The addition of whole-body positron emission tomography-computed tomography (PET/CT) leads to further nodal evaluation and informs radiotherapeutic treatment planning for curative cases. Anal canal cancers, located between the anorectal

enflame

Treatment of Advanced Anal Cancer,umumab have also been used. Checkpoint inhibitors such as nivolumab and pembrolizumab have demonstrated some efficacy in refractory metastatic anal squamous cell carcinoma. In oligometastatic disease, locoregional approaches after initial systemic therapy have seen some success in highly selected pa